Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Report

Global and Region Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：236
  • REPORT CODE：GMM970465
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Vascular Endothelial Growth Factor (VEGF) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Vascular Endothelial Growth Factor (VEGF) Inhibitorsmarket, defines the market attractiveness level of Vascular Endothelial Growth Factor (VEGF) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Vascular Endothelial Growth Factor (VEGF) Inhibitors industry, describes the types of Vascular Endothelial Growth Factor (VEGF) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market and the development prospects and opportunities of Vascular Endothelial Growth Factor (VEGF) Inhibitors industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market in Chapter 13.

    By Player:

    • F Hoffmann-La Roche Ltd

    • Sanofi

    • Bayer AG

    • Regeneron Pharmaceuticals Inc

    • Novartis AG

    By Type:

    • VEGF-A Inhibitor

    • VEGF-B Inhibitor

    • VEGF-C Inhibitor

    • VEGF-D Inhibitor

    By End-User:

    • Oncology

    • Ophthalmology

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis and Outlook to 2022

    • 7.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    • 7.2 United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    • 7.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    • 7.4 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    • 7.5 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    • 7.6 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    • 7.7 South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption (2017-2022)

    8 Region and Country-wise Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis and Outlook to 2028

    • 8.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    • 8.2 United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    • 8.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    • 8.4 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    • 8.5 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    • 8.6 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    • 8.7 South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast (2022-2028)

    9 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Outlook by Types and Applications to 2022

    • 9.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global VEGF-A Inhibitor Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global VEGF-B Inhibitor Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global VEGF-C Inhibitor Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global VEGF-D Inhibitor Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ophthalmology Consumption and Growth Rate (2017-2022)

    10 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Outlook by Types and Applications to 2028

    • 10.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global VEGF-A Inhibitor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global VEGF-B Inhibitor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global VEGF-C Inhibitor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global VEGF-D Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    11 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Competitive Analysis

    • 14.1 F Hoffmann-La Roche Ltd

      • 14.1.1 F Hoffmann-La Roche Ltd Company Details

      • 14.1.2 F Hoffmann-La Roche Ltd Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 F Hoffmann-La Roche Ltd Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • 14.2 Sanofi

      • 14.2.1 Sanofi Company Details

      • 14.2.2 Sanofi Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • 14.4 Regeneron Pharmaceuticals Inc

      • 14.4.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.4.2 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • 14.5 Novartis AG

      • 14.5.1 Novartis AG Company Details

      • 14.5.2 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Vascular Endothelial Growth Factor (VEGF) Inhibitors

    • Figure Vascular Endothelial Growth Factor (VEGF) Inhibitors Picture

    • Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption by Country (2017-2022)

    • Figure United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)

    • Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure China Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure India Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast by Country (2022-2028)

    • Figure United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VEGF-A Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global VEGF-B Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global VEGF-C Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global VEGF-D Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)

    • Figure Global VEGF-A Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VEGF-B Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VEGF-C Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global VEGF-D Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Export by Region (Top 5 Countries) (2017-2028)

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US